Latest California Healthline Stories
Veterans Courted In California’s Ballot Fight Over Curbing Drug Prices
The initiative would prohibit California state agencies from paying more for a prescription drug than what the Department of Veterans Affairs pays. Both sides are deploying veterans’ sympathetic and trusted image to win over voters.
Candidates Decry High Drug Prices But Have Few Options For Voters
Drug prices rise for a variety of reasons but opportunities for the government to control them is limited.
Study: Family Caregivers Need Help, Too
A study by the National Academies finds more support is needed for nearly 18 million people giving care to family members 65 and older.
Newly Covered By Medi-Cal, Undocumented Children Also Seek Dental Care
Some dental clinics are expanding their hours to meet demand, but can an already stressed system satisfy the needs of children who haven’t seen a dentist in years?
Study Says Concerns About Orphan Drug Spending Are Unjustified
A study in Health Affairs concludes that orphan drugs for rare diseases are not having a widespread or deep impact on health care spending.
Consumer Group Questions Role of Drug Costs In California Premium Hikes
Consumers Union says Anthem Inc. and Blue Shield of California may be exploiting furor over prescription drug prices. State regulators are looking into the issue.
Behind The EpiPen Monopoly: Lobbying, Flailing Competition And Tragedy
The death of a Sacramento girl paved the way for a state law that strengthened the demand for EpiPens in California.
EpiPen Controversy Fuels Concerns Over Generic Drug Approval Backlog
Four years after a huge push to speed generics to market, the FDA has more than 4,000 generics waiting for approval.
High-Profile Initiative To Pool Medical Records Lags In California
‘Progress has been slower than we hoped,’ says one official at Cal INDEX, backed by $80 million from two large insurers.
Cardiac Rehab Improves Health, But Cost And Access Issues Complicate Success
Research shows exercise-based cardiac rehab programs help heart patients heal faster and live longer. But fewer than a third take part. Time and cost are the main barriers, doctors and patients say.